About Hillhurst Biopharmaceuticals
Hillhurst Biopharmaceuticals is a private company based in Montrose, California. It has reported $1,837,500 raised in one offering on Form D since September 2023. Its chief executive is Andrew Gomperts.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 11, 2023 | Sep 26, 2023 | $1,837,500fully sold | 10 | $183K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Hillhurst Biopharmaceuticals's Form D filed Sep 26, 2023.
JF
Jeff Friedman
Director
AG
Andrew Gomperts
Chief Executive Officer and director
EG
Edward Gomperts
Executive officer and director